Publications by authors named "Li-Xiang Cheng"

Claim this Profile
U
Ultrafine percutaneous transhepatic cholangioscopy for biliary biopsy among patients with suspected malignant biliary obstruction.
Hai-Feng Zhou, Wei-Zhong Zhou, Hai-Bin Shi, Wei Yang, Zhong-Wei Xu, Xiang-Cheng Li

HPB (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma: A multicenter study.
Yuan Cheng, Jun-Ying Wang, You Lu, Yong-Xiang Xia, Hui Zhao, Xiang-Cheng Li

Hepatobiliary Pancreat Dis Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy.
Kong-Ying Lin, Hong-Zhi Liu, Jian-Wei Liu, Xiao-Dong Zhu, Yang-Xun Pan, Xiang-Cheng Li

Eur J Surg Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative clinical and contrasted-enhanced CT features to predict perineural invasion in gallbladder carcinoma: focus on clinical T3-4 stage.
Lu Chen, Yang Zhou, Xun Xu, Hui Zhang, Xuan Xiao, Xiang-Cheng Li

Abdom Radiol (NY)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.
Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Xiang-Cheng Li

Clin Mol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study.
Jin-Hong Chen, Lu Lu, Xiao-Yun Zhang, Bang-De Xiang, Xiao Xu, Xiang-Cheng Li

Hepatobiliary Pancreat Dis Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Particular Chinese contributions to extracorporeal liver surgery.
Abudusalamu Aini, Qian Lu, Hao Wen, Wen-Tao Wang, Tuerganaili Aji, Xiang-Cheng Li

Hepatobiliary Pancreat Dis Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation and immunosuppressive function of CD19CD24CD27 regulatory B cells are regulated through the miR-29a-3p/NFAT5 pathway.
Jin-Yang Li, Tian-Shuo Feng, Ji Gao, Xin-Xiang Yang, Xiang-Cheng Li

Hepatobiliary Pancreat Dis Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p.
Rui Xiang Chen, Shuo Chen Liu, Xue Chun Kan, Yi Rui Wang, Ji Fei Wang, Xiang Cheng Li

Adv Sci (Weinh)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein A-1 Accelerated Liver Regeneration Through Regulating Autophagy Via AMPK-ULK1 Pathway.
Zi Yi Wang, Rui Xiang Chen, Ji Fei Wang, Shuo Chen Liu, Xiao Xu, Xiang Cheng Li

Cell Mol Gastroenterol Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights.
Gu-Wei Ji, Qing Xu, Chen-Yu Jiao, Ming Lu, Zheng-Gang Xu, Xiang-Cheng Li

JHEP Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.
Guo-Ming Shi, Xiao-Yong Huang, Tian-Fu Wen, Tian-Qiang Song, Ming Kuang, Xiang-Cheng Li

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein A-1 protected hepatic ischaemia-reperfusion injury through suppressing macrophage pyroptosis via TLR4-NF-κB pathway.
Rui-Xiang Chen, Wang-Jie Jiang, Shuo-Chen Liu, Zi-Yi Wang, Zhi-Bo Wang, Xiang-Cheng Li

Liver Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT-based clinico-radiological nomograms for prognosis prediction in patients with intrahepatic mass-forming cholangiocarcinoma: a multi-institutional study.
Chen Yu Jiao, Hui Zhang, Gu Wei Ji, Qing Xu, Ming Lu, Xiang Cheng Li

Eur Radiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a gradient boosting machine to predict prognosis after liver resection for intrahepatic cholangiocarcinoma.
Gu-Wei Ji, Chen-Yu Jiao, Zheng-Gang Xu, Xiang-Cheng Li, Ke Wang

BMC Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection.
Gu-Wei Ji, Ye Fan, Dong-Wei Sun, Ming-Yu Wu, Ke Wang, Xiang-Cheng Li

J Hepatocell Carcinoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract Cancer.
Gu-Wei Ji, Ke Wang, Yong-Xiang Xia, Jin-Song Wang, Xue-Hao Wang, Xiang-Cheng Li

Ann Surg Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer.
Poshita-Kumari Seesaha, Kang-Xin Wang, Guo-Qun Wang, Ting-Yun Cui, Feng-Jiao Zhao, Xiang-Cheng Li

Onco Targets Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways.
Chen Yu Jiao, Qin Chao Feng, Chang Xian Li, Dong Wang, Sheng Han, Xiang Cheng Li

Cell Death Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "When Should Hepatectomy be Performed for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma?".
Chang Xian Li, Rui Xiang Chen, Xiang Cheng Li

Ann Surg Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism.
Chang Xian Li, Hong Wei Wang, Wang Jie Jiang, Gao Chao Li, Yao Dong Zhang, Xiang Cheng Li

Oxid Med Cell Longev· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Strategies for the Treatment of Bismuth Type I and II Hilar Cholangiocarcinoma: Bile Duct Resection with or Without Hepatectomy?
Rui Xiang Chen, Chang Xian Li, Cheng Huan Luo, Hui Zhang, Tao Zhou, Xiang Cheng Li

Ann Surg Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Pre- and Post-Operative Models to Predict Recurrence After Resection of Solitary Hepatocellular Carcinoma: A Multi-Institutional Study.
Ming-Yu Wu, Qian Qiao, Ke Wang, Gu-Wei Ji, Bing Cai, Xiang-Cheng Li

Cancer Manag Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 Suppresses Liver Tumor Growth and Metastasis by Reducing Circulating Regulating T Cells and Enhancing the Anti-Tumor Effect of Rapamycin.
Chang Xian Li, Xin Xiang Yang, Hong Wei Wang, Xiang Cheng Li, Kevin Tak-Pan Ng

Onco Targets Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-30a-5p promotes cholangiocarcinoma cell proliferation through targeting SOCS3.
Jia Wei Zhang, Xing Wang, Gao Chao Li, Dong Wang, Sheng Han, Xiang Cheng Li

J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis